Vireo Growth (VREOF) EV to EBIT (2020 - 2026)
Vireo Growth (VREOF) EV to EBIT (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EV to EBIT |
|---|---|---|---|---|---|
| 1 | Haleon | 89.55 Bn | 87.69 Bn | - | 26.84 |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | 14.05 |
| 3 | Zoetis | 32.71 Bn | 30.77 Bn | 1.62 Bn | 8.48 |
| 4 | Takeda Pharmaceutical | 27.65 Bn | 23.59 Bn | 4.39 Bn | -19.36 |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn | 14.65 |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | -0.08 |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | 132.71 |
| 8 | Neurocrine Biosciences | 17.84 Bn | 16.52 Bn | 800.70 Mn | 20.94 |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 20.05 |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn | 1,735.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 23, 2026 | 1,742.62 |
| Jul 22, 2026 | 1,748.05 |
| Jul 21, 2026 | 1,739.01 |
| Jul 20, 2026 | 1,746.24 |
| Jul 17, 2026 | 1,746.24 |
| Jul 16, 2026 | 1,755.28 |
| Jul 15, 2026 | 1,780.59 |
| Jul 14, 2026 | 1,784.21 |
| Jul 13, 2026 | 1,773.36 |
| Jul 10, 2026 | 1,764.32 |
| Jul 9, 2026 | 1,764.32 |
| Jul 8, 2026 | 1,800.48 |
| Jul 7, 2026 | 1,778.78 |
| Jul 6, 2026 | 1,737.20 |
| Jul 2, 2026 | 1,773.36 |
| Jul 1, 2026 | 1,702.85 |
| Jun 30, 2026 | 1,789.63 |
| Jun 29, 2026 | 1,823.98 |
| Jun 26, 2026 | 1,778.78 |
| Jun 25, 2026 | 1,782.40 |